Rudolf P Buhs

Title: Rudolf P Buhs: Innovator in Antiparasitic Compounds

Introduction

Rudolf P Buhs is a notable inventor based in Short Hills, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of new antiparasitic agents. His work has led to advancements that could benefit both human and animal health.

Latest Patents

Rudolf P Buhs holds a patent for "Derivatives of C-076 compounds." This patent discloses new derivatives of C-076 compounds that have been isolated from the livers of animals administered ivermectin. The in vitro incubation of these compounds with animal liver preparations has revealed that they retain the basic ivermectin structure. However, the 24-methyl group has been oxidized to a hydroxy methyl group. In some of the new compounds, the disaccharide substituent of the starting materials has been cleaved to a monosaccharide moiety. These new compounds have been found to retain the biological activity of the parent C-076 compounds, making them potent antiparasitic agents. The patent also includes compositions and methods for their use.

Career Highlights

Rudolf P Buhs is associated with Merck & Co., Inc., a leading global healthcare company. His work at Merck has allowed him to focus on innovative solutions in the pharmaceutical industry. With a patent count of 1 patent, Buhs continues to contribute to the advancement of medical science.

Collaborations

Throughout his career, Buhs has collaborated with notable colleagues, including Theodore A Jacob and Rae Taub. These collaborations have fostered an environment of innovation and have led to significant advancements in their respective fields.

Conclusion

Rudolf P Buhs is a distinguished inventor whose work in developing derivatives of C-076 compounds has the potential to impact the field of antiparasitic treatments significantly. His contributions to Merck & Co., Inc. and the pharmaceutical industry highlight the importance of innovation in healthcare.